Anzeige
Mehr »
Samstag, 24.01.2026 - Börsentäglich über 12.000 News
Gold vor 5.000-USD-Marke: Über 2 Mio. Unzen Gold - und trotzdem erst 63 Mio. USD Börsenwert?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 898321 | ISIN: AU000000COH5 | Ticker-Symbol: OC5
Hamburg
23.01.26 | 17:25
158,78 Euro
-0,75 % -1,20
Branche
Gesundheitswesen
Aktienmarkt
S&P/ASX 50
1-Jahres-Chart
COCHLEAR LIMITED Chart 1 Jahr
5-Tage-Chart
COCHLEAR LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
157,88161,0823.01.
158,42160,1223.01.

Aktuelle News zur COCHLEAR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoCochlear stock rating upgraded by RBC Capital on growth outlook1
MoCOCHLEAR LIMITED: Notice of HY26 result analyst and media briefing1
11.01.Cochlear shares lag the ASX 200 after a tough year. Is it time to buy?2
18.12.25COCHLEAR LIMITED: Notification of cessation of securities - COH-
18.12.25COCHLEAR LIMITED: Notification regarding unquoted securities - COH-
18.12.25Envoy Medical, Inc.: Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant241White Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
16.12.25Envoy Medical, Inc.: Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio230White Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
COCHLEAR Aktie jetzt für 0€ handeln
10.12.25Envoy Medical, Inc.: Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant325White Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
04.12.25Envoy Medical, Inc.: Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient286White Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions...
► Artikel lesen
02.12.25Cochlear-aligned biotech off to a lacklustre start on the ASX6
25.11.25Biocurious: Cochlear-backed Epiminder strives to raise the bar on epilepsy monitoring2
21.11.25Cochlear baut Produktmanagement aus4
20.11.25Envoy Medical, Inc.: Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery443White Bear Lake, Minnesota--(Newsfile Corp. - November 20, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
20.11.25Cochlear Implant Surgery Reduces Dementia Risk by Two-thirds5
18.11.25Envoy Medical, Inc.: Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial272White Bear Lake, Minnesota--(Newsfile Corp. - November 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
17.11.25COCHLEAR LIMITED: Change in substantial holding1
12.11.25COCHLEAR LIMITED: Appendix 3Y - Diggory Howitt-
12.11.25COCHLEAR LIMITED: Notification regarding unquoted securities - COH-
12.11.25COCHLEAR LIMITED: Ceasing to be a substantial holder-
12.11.25This Cochlear-backed ASX aspirant will be targeting an epilepsy market worth north of $1 billion2
Weiter >>
78 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1